Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting ; volume:8 ; number:1 ; day:04 ; month:7 ; year:2008 ; pages:1-8 ; date:12.2008
BMC infectious diseases ; 8, Heft 1 (04.7.2008), 1-8, 12.2008
- Creator
-
Badri, Motasim
- Contributor
-
Lawn, Stephen D.
Wood, Robin
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-8-89
- URN
-
urn:nbn:de:1111-2016030252617
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Badri, Motasim
- Lawn, Stephen D.
- Wood, Robin
- SpringerLink (Online service)
Other Objects (12)
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Estimating health workforce needs for antiretroviral therapy in resource-limited settings
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Estimating health workforce needs for antiretroviral therapy in resource-limited settings
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome